176 related articles for article (PubMed ID: 31398195)
21. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region.
Luciani S; Caixeta R; Chavez C; Ondarsuhu D; Hennis A
BMJ Open; 2023 Mar; 13(3):e070085. PubMed ID: 36863746
[TBL] [Abstract][Full Text] [Related]
22. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.
McGettigan P; Henry D
PLoS Med; 2013; 10(2):e1001388. PubMed ID: 23424288
[TBL] [Abstract][Full Text] [Related]
23. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
[TBL] [Abstract][Full Text] [Related]
24. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines.
Ng'ang'a J; Chitimbe T; Mburu R; Rushwan S; Ntirushwa D; Chinery L; Gülmezoglu AM
Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):11-13. PubMed ID: 35762803
[TBL] [Abstract][Full Text] [Related]
25. Patent and exclusivity status of essential medicines for non-communicable disease.
Mackey TK; Liang BA
PLoS One; 2012; 7(11):e51022. PubMed ID: 23226453
[TBL] [Abstract][Full Text] [Related]
26. WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
Rowlands A; Acosta-Gualandri A; Guevara-Aguirre J; Chanoine JP
BMJ Glob Health; 2016; 1(3):e000114. PubMed ID: 28588968
[TBL] [Abstract][Full Text] [Related]
27. Comparison of essential medicines lists in 137 countries.
Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
[TBL] [Abstract][Full Text] [Related]
28. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
[TBL] [Abstract][Full Text] [Related]
29. Essential medicines for reproductive health: developing evidence based interagency list.
Logez S; Jayasekar S; Moller H; Ahmed K; Patel MU
South Med Rev; 2011 Dec; 4(2):62-8. PubMed ID: 23093884
[TBL] [Abstract][Full Text] [Related]
30. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
Bazargani YT; Ugurlu M; de Boer A; Leufkens HGM; Mantel-Teeuwisse AK
BMC Cardiovasc Disord; 2018 Jun; 18(1):126. PubMed ID: 29940880
[TBL] [Abstract][Full Text] [Related]
31. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
32. Prescription of potentially inappropriate medicines and comparison with lists of essential medicines for treatment of chronic disorders in older patients.
Gu J; Li SJ; Yu A; Xing Z; Kong J; Yang J; Wang YH
Arch Gerontol Geriatr; 2023 Jun; 109():104939. PubMed ID: 36746015
[TBL] [Abstract][Full Text] [Related]
33. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
[TBL] [Abstract][Full Text] [Related]
34. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
35. Availability, Costs and Stock-Outs of Essential NCD Drugs in Three Rural Rwandan Districts.
Mukundiyukuri JP; Irakiza JJ; Nyirahabimana N; Ng'ang'a L; Park PH; Ngoga G; El-Khatib Z; Nditunze L; Dusengeyezu E; Rusangwa C; Mpunga T; Mubiligi J; Hedt-Gauthier B
Ann Glob Health; 2020 Sep; 86(1):123. PubMed ID: 33024709
[TBL] [Abstract][Full Text] [Related]
36. Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries.
Bruyn E; Nguyen L; Schutte AE; Murphy A; Perel P; Webster R
Glob Heart; 2022; 17(1):6. PubMed ID: 35174047
[TBL] [Abstract][Full Text] [Related]
37. Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.
Kadyrova N; Gotham D; Kniazkov S; Aghayev E; Hajibalayev P; Ermatov Z; Azzopardi Muscat N
PLoS One; 2023; 18(12):e0294680. PubMed ID: 38060531
[TBL] [Abstract][Full Text] [Related]
38. How effective was implementation of the package of essential non-communicable disease (PEN) interventions: A review of evidence?
Tripathy JP; Mishra S
Diabetes Metab Syndr; 2021; 15(5):102266. PubMed ID: 34496339
[TBL] [Abstract][Full Text] [Related]
39. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
[TBL] [Abstract][Full Text] [Related]
40. Preparedness of primary health care facilities on implementation of essential non-communicable disease interventions in osun state south-west Nigeria: a rural-urban comparative study.
Akinwumi AF; Esimai OA; Arije O; Ojo TO; Esan OT
BMC Health Serv Res; 2023 Feb; 23(1):154. PubMed ID: 36788557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
